Previous studies with JQ1 and other BET inhibitors in glioma and other cancers shows that the effects of BET inhibition are primarily antiproliferative while having little effect on cytotoxicity (Pastori et al. 2014; Filippakopoulos et al. 2010; Cheng et al. 2013). This evidence concerns the gene DNER and central nervous system cancer.